Results 191 to 200 of about 38,893 (219)

Discontinuation of SGLT2i After a Urogenital Infection: A Population‐Based Matched Cohort Study of Patients With Type 2 Diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5740-5750, July 2026.
ABSTRACT Aims Sodium‐glucose cotransporter 2 inhibitors (SGLT2is) improve glycaemic control and cardiorenal outcomes in Type 2 diabetes, particularly in patients at elevated cardiovascular and kidney risk, yet discontinuation following infections appears common.
Christine Ljungberg, Mette Nørgaard, Christina Vandenbroucke‐Grauls, Michael Dalager‐Pedersen, Henrik Toft Sørensen, Reimar Wernich Thomsen   +5 more
wiley   +1 more source

Cochrane in CORR® : Opioid Agonist Treatment for People Who are Dependent on Pharmaceutical Opioids. [PDF]

Clin Orthop Relat Res
Madden K.
europepmc   +1 more source

Vaping to quit smoking: Qualitative study of people receiving opioid agonist treatment. [PDF]

Drug Alcohol Rev
Kypri K, Austin E, Jackson M, Wright K, Shui A, Li A, Sathasivam V, Bonevski B, Dunlop AJ.   +8 more
europepmc   +1 more source

Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study. [PDF]

Addiction
Santo TJ, Chaillon A, Martin N, Hickman M, Jones N, Farrell M, Bharat C, Degenhardt L, Borquez A.   +8 more
europepmc   +1 more source

Universal Health Coverage of Opioid Agonist Treatment in Norway: An Equity-Adjusted Economic Evaluation. [PDF]

Pharmacoeconomics
Chaudhary P, Fadnes LT, Fosse S, Chalabianloo F, Johansson KA.   +4 more
europepmc   +1 more source

Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada. [PDF]

BMJ Open
Yan R, Hossain MB, Min JE, Kurz M, Smith K, Piske M, Seaman S, Bach P, Karim E, Platt RW, Siebert U, Socías ME, Xie H, Nosyk B.   +13 more
europepmc   +1 more source

Examining opioid agonist treatment (OAT) site operations and early signals of change in the first year of British Columbia's drug decriminalization policy: Insights from a provincial survey. [PDF]

Can J Public Health
Russell C, Law J, Hodgson K, MacKinnon L, Shahin R, Crichlow F, Patenaude S, Imtiaz S, Rehm J, Ali F.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study

Drug and Alcohol Dependence, 2021
Alexandria Macmadu, Kimberly Paull, Elizabeth A Samuels   +2 more
exaly